Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by Boston Scientific Corporation

evt | Article | May 2019 Supplement

Case Report: Utilizing IVUS Below-the-Knee

The importance of invasive imaging to guide treatment decisions and improve outcomes.

By Steve Henao, MD, FACS, FACC

evt | Article | August 2018

Left Superficial Femoral Artery Occlusion in a Patient With an Aortobifemoral Graft

Moderator: Ehrin J. Armstrong, MD
Panel: Steve Henao, MD, FACC, FACS; Sahil A. Parikh, MD, FACC, FSCAI; and Saher Sabri, MD, FSIR

Sponsored by TriVascular, Inc.

evt | Article | November 2015

Improving Procedural Predictability in EVAR

New TriVascular Ovation iX™ Delivery System adds integrated sheath and an additional option for gate cannulation.

By Steve Henao, MD, FACS, FACC

Sponsored by Boston Scientific Corporation

evt | Article | January 2019 Supplement

A Roundtable Discussion on Results From the First Head-to-Head DES SFA Trial: IMPERIAL

A multidisciplinary panel of PAD experts discuss the impact on patient care and the health care system and how these results may shift current treatment algorithms.

With Michael R. Jaff, DO; Gary M. Ansel, MD, FACC; William A. Gray, MD; Steve Henao, MD, FACC, FACS; and Robert A. Lookstein, MD

Advertisement

evt | News | March 30, 2017

Endologix's ELEVATE IDE Clinical Trial Begins Patient Enrollment

March 31, 2017—Endologix, Inc. has announced that the company’s Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft (ELEVATE) IDE clinical study has begun enrollment and treatment of its first patients.

evt | News | August 3, 2015

FDA Approves TriVascular's Ovation iX Abdominal Stent Graft System

August 4, 2015—TriVascular Technologies, Inc. announced that the US Food and Drug Administration approved the company’s next-generation Ovation iX “integrated exchange” abdominal stent graft system for endovascular repair of abdominal aortic aneurysms (AAA).  According to the company, the Ovation iX’s delivery system enhancements are designed to provide additional flexibility for more predictable deployment and greater ease of use.

Sponsored by Boston Scientific Corporation

evt | Article | May 2021

The Changing Landscape of Medical Education: Making Online Learning Personal and Effective

Breaking the mold to provide customized curricula on demand to improve patient care.

By Michael R. Jaff, DO, FACP, FACC

evt | News | September 18, 2019

FDA Approves PROMISE II Pivotal Study of LimFlow System to Treat Chronic Limb-Threatening Ischemia

September 19, 2019—LimFlow SA, a France-based developer of minimally invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), announced that the FDA has approved the company’s investigational device exemption for the PROMISE II pivotal study of the LimFlow percutaneous deep vein arterialization system.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button